Alternative Dosing And Prevention of Transfusions (ADAPT)
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
ADAPT is a prospective cohort study at Jinja Regional Referral Hospital (JRRH) primarily to
assess the effect of hydroxyurea on blood transfusion utilization and secondarily to
determine the feasibility of PK-guided hydroxyurea dosing.